Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
- PMID: 1510386
- DOI: 10.1002/ana.410320715
Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
Abstract
Although the cause of neuronal death in Parkinson's disease remains unknown, a hyperoxidation phenomenon has been implicated as a potential cytotoxic mechanism. Catecholaminergic neurons containing neuromelanin, an autoxidation byproduct of catecholamines, are more vulnerable in Parkinson's disease than nonmelanized catecholaminergic neurons. High levels of CuZn superoxide dismutase mRNA have been observed in the substantia nigra, suggesting that high levels of oxygen free radicals are indeed produced in the structure. Catecholaminergic neurons surrounded by a low density of glutathione peroxidase cells are more susceptible to degeneration in Parkinson's disease than those well protected against oxidative stress. The nigral content in iron, a compound that exacerbates the production of free radicals in catecholaminergic neurons, is increased in Parkinson's disease. Altogether these data suggest that hyperoxidation may participate in the selective vulnerability of catecholaminergic neurons in Parkinson's disease.
Similar articles
-
Does oxidative stress participate in nerve cell death in Parkinson's disease?Eur Neurol. 1993;33 Suppl 1:52-9. doi: 10.1159/000118538. Eur Neurol. 1993. PMID: 8375433 Review.
-
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.Ann Neurol. 1992;32 Suppl:S82-7. doi: 10.1002/ana.410320714. Ann Neurol. 1992. PMID: 1510385 Review.
-
Oxidative mechanisms in nigral cell death in Parkinson's disease.Mov Disord. 1998;13 Suppl 1:24-34. Mov Disord. 1998. PMID: 9613715 Review.
-
What process causes nigral cell death in Parkinson's disease?Neurol Clin. 1992 May;10(2):387-403. Neurol Clin. 1992. PMID: 1584181 Review.
-
Neuronal vulnerability in Parkinson's disease.J Neural Transm Suppl. 1997;50:79-88. doi: 10.1007/978-3-7091-6842-4_9. J Neural Transm Suppl. 1997. PMID: 9120427 Review.
Cited by
-
An immunohistochemical study of the neuronal expression of manganese superoxide dismutase in sporadic amyotrophic lateral sclerosis.Acta Neuropathol. 1994;88(2):151-8. doi: 10.1007/BF00294508. Acta Neuropathol. 1994. PMID: 7985495
-
Temperature-induced reversible conformational change in the first 100 residues of alpha-synuclein.Protein Sci. 2006 Mar;15(3):602-8. doi: 10.1110/ps.051867106. Epub 2006 Feb 1. Protein Sci. 2006. PMID: 16452621 Free PMC article.
-
Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian.J Neural Transm (Vienna). 2005 Sep;112(9):1237-48. doi: 10.1007/s00702-004-0256-2. Epub 2005 Jan 24. J Neural Transm (Vienna). 2005. PMID: 15666038
-
Role of calpain in apoptosis.Cell J. 2011 Summer;13(2):65-72. Epub 2011 Aug 24. Cell J. 2011. PMID: 23507938 Free PMC article.
-
Therapeutic vitamin A doses increase the levels of markers of oxidative insult in substantia nigra and decrease locomotory and exploratory activity in rats after acute and chronic supplementation.Neurochem Res. 2008 Mar;33(3):378-83. doi: 10.1007/s11064-007-9438-2. Epub 2007 Aug 22. Neurochem Res. 2008. PMID: 17712631
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
